Raul H. Murillo (Colombia)

Hospital Universitario San Ignacio Centro Javeriano de Oncología

MD, MPH, Fellow PAHO International Health, PhDc. Currently Director of the Javeriana Oncology Center (San Ignacio University Hospital - Bogotá, Colombia), and Assistant Professor Faculty of Medicine at the Pontifical Javeriana University. Formerly Senior Scientist at the International Agency for Research on Cancer and Director General of the National Cancer Institute of Colombia. About 20 years of cancer research with emphasis on early diagnosis of breast and cervical cancer. Collaborative external consultant for institutions such as the Breast Health Global Initiative, American Association for Cancer Research, World Health Organization, and Pan American Health Organization.

Presenter of 2 Presentations

Conference Calendar

Workshop 2: Screening / Treatment Hall B

Surveillance screening / treatment (ID 85)

Session Date

07/20/2020

Session Time

11:00 - 12:25

Room

Hall B

Session Type

Public Health

Session Name

Workshop 2: Screening / Treatment

Lecture Time

12:03 - 12:23

Presenter

Raul H. Murillo (Colombia)

Authors

Raul H. Murillo (Colombia)

Oral Session 13: SCREENING V. Evaluation and Impact of cervical cancer screening Hall E

EVOLVEMENT OF CERVICAL CANCER SCREENING PROGRAMS IN LATIN AMERICA (ID 855)

Session Date

07/23/2020

Session Time

12:20 - 14:20

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 13: SCREENING V. Evaluation and Impact of cervical cancer screening

Lecture Time

13:20 - 13:32

Presenter

Raul H. Murillo (Colombia)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Moderator of 1 Session

Conference Calendar

Dedicated Symposium

01040 - Global Supply, Demand, and Pricing for HPV Vaccines and HPV Testing (ID 65)

Session Type

Dedicated Symposium

Session Date

07/24/2020

Session Time

14:15 - 15:20

Room

Hall A

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"Introduction by Chairs \u003Csmall\u003E(ID 1379)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1379,"presentation":"Introduction by Chairs \u003Csmall\u003E(ID 1379)\u003C\/small\u003E","session":"Global Supply, Demand, and Pricing for HPV Vaccines and HPV Testing","presenter":"Karen Canfell (Australia)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/1473.jpg"},"playlist":[{"name":"Introduction by Chairs","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/1379 Karen Canfell.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/65\/1379 Karen Canfell.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/40A4B364.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/1379 Karen Canfell.vtt"}]},{"name":"HPV vaccine. Global market dynamics \u003Csmall\u003E(ID 1380)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1380,"presentation":"HPV vaccine. Global market dynamics \u003Csmall\u003E(ID 1380)\u003C\/small\u003E","session":"Global Supply, Demand, and Pricing for HPV Vaccines and HPV Testing","presenter":"Tania Cernuschi (Switzerland)","photo":""},"playlist":[{"name":"HPV vaccine. Global market dynamics","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/HPV vaccine. Global market dynamics.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/65\/HPV vaccine. Global market dynamics.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/A1D6A800.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/HPV vaccine. Global market dynamics.vtt"}]},{"name":"HPV screening. Global market dynamics \u003Csmall\u003E(ID 1381)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1381,"presentation":"HPV screening. Global market dynamics \u003Csmall\u003E(ID 1381)\u003C\/small\u003E","session":"Global Supply, Demand, and Pricing for HPV Vaccines and HPV Testing","presenter":"Mario Poljak (Slovenia)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/282.jpg"},"playlist":[{"name":"HPV screening. Global market dynamics","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/1381 Mario Poljak.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/65\/1381 Mario Poljak.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/17E18E86.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/1381 Mario Poljak.vtt"}]},{"name":"Panel Discussion \u003Csmall\u003E(ID 1725)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1725,"presentation":"Panel Discussion \u003Csmall\u003E(ID 1725)\u003C\/small\u003E","session":"Global Supply, Demand, and Pricing for HPV Vaccines and HPV Testing","presenter":"","photo":""},"playlist":[{"name":"Panel Discussion of IPVC session Virtual session on Global Supply Demand and Pricing for HPV Vaccine","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/Panel Discussion of IPVC session Virtual session on Global Supply Demand, and Pricing for HPV Vaccines and HPV Testing.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/65\/Panel Discussion of IPVC session Virtual session on Global Supply Demand, and Pricing for HPV Vaccines and HPV Testing.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/CC08F895.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/65\/Panel Discussion of IPVC session Virtual session on Global Supply Demand, and Pricing for HPV Vaccines and HPV Testing.vtt"}]}]